Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.

CONTEXT Laboratory and epidemiological data suggest that folic acid may have an antineoplastic effect in the large intestine. OBJECTIVE To assess the safety and efficacy of folic acid supplementation for preventing colorectal adenomas. DESIGN, SETTING, AND PARTICIPANTS A double-blind, placebo-controlled, 2-factor, phase 3, randomized clinical trial conducted at 9 clinical centers between July 6, 1994, and October 1, 2004. Participants included 1021 men and women with a recent history of colorectal adenomas and no previous invasive large intestine carcinoma. INTERVENTION Participants were randomly assigned in a 1:1 ratio to receive 1 mg/d of folic acid (n = 516) or placebo (n = 505), and were separately randomized to receive aspirin (81 or 325 mg/d) or placebo. Follow-up consisted of 2 colonoscopic surveillance cycles (the first interval was at 3 years and the second at 3 or 5 years later). MAIN OUTCOME MEASURES The primary outcome measure was occurrence of at least 1 colorectal adenoma. Secondary outcomes were the occurrence of advanced lesions (> or =25% villous features, high-grade dysplasia, size > or =1 cm, or invasive cancer) and adenoma multiplicity (0, 1-2, or > or =3 adenomas). RESULTS During the first 3 years, 987 participants (96.7%) underwent colonoscopic follow-up, and the incidence of at least 1 colorectal adenoma was 44.1% for folic acid (n = 221) and 42.4% for placebo (n = 206) (unadjusted risk ratio [RR], 1.04; 95% confidence interval [CI], 0.90-1.20; P = .58). Incidence of at least 1 advanced lesion was 11.4% for folic acid (n = 57) and 8.6% for placebo (n = 42) (unadjusted RR, 1.32; 95% CI, 0.90-1.92; P = .15). A total of 607 participants (59.5%) underwent a second follow-up, and the incidence of at least 1 colorectal adenoma was 41.9% for folic acid (n = 127) and 37.2% for placebo (n = 113) (unadjusted RR, 1.13; 95% CI, 0.93-1.37; P = .23); and incidence of at least 1 advanced lesion was 11.6% for folic acid (n = 35) and 6.9% for placebo (n = 21) (unadjusted RR, 1.67; 95% CI, 1.00-2.80; P = .05). Folic acid was associated with higher risks of having 3 or more adenomas and of noncolorectal cancers. There was no significant effect modification by sex, age, smoking, alcohol use, body mass index, baseline plasma folate, or aspirin allocation. CONCLUSIONS Folic acid at 1 mg/d does not reduce colorectal adenoma risk. Further research is needed to investigate the possibility that folic acid supplementation might increase the risk of colorectal neoplasia. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT00272324.

[1]  B. Ames,et al.  DNA damage in folate deficiency. , 1995, Bailliere's clinical haematology.

[2]  J. Scott,et al.  Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. , 1997, Methods in enzymology.

[3]  E. Riboli,et al.  Low folate levels may protect against colorectal cancer , 2006, Gut.

[4]  A. Feinberg,et al.  Reduced genomic 5-methylcytosine content in human colonic neoplasia. , 1988, Cancer research.

[5]  G. Young,et al.  Folate deficiency reduces the development of colorectal cancer in rats. , 2000, Carcinogenesis.

[6]  R. Hoover,et al.  Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. , 2006, The American journal of clinical nutrition.

[7]  P. V. van Helden,et al.  Hypomethylation of DNA in pathological conditions of the human prostate. , 1987, Cancer research.

[8]  M. Thun,et al.  Folate nutrition and prostate cancer incidence in a large cohort of US men. , 2006, American journal of epidemiology.

[9]  F. Speizer,et al.  Multivitamin Use, Folate, and Colon Cancer in Women in the Nurses' Health Study , 1998, Annals of Internal Medicine.

[10]  D. Albanes,et al.  Colorectal cancer and folate status: a nested case-control study among male smokers. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  P. Stattin,et al.  Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: A prospective study , 2005, International journal of cancer.

[12]  P. Ueland,et al.  Automated assay for the determination of methylmalonic acid, total homocysteine, and related amino acids in human serum or plasma by means of methylchloroformate derivatization and gas chromatography-mass spectrometry. , 2005, Clinical chemistry.

[13]  Nutrition in health and disease Nutrition , 2004 .

[14]  J. Mills,et al.  Fortification of foods with folic acid--how much is enough? , 2000, The New England journal of medicine.

[15]  A. Razin,et al.  DNA methylation and gene expression , 1991, Microbiological reviews.

[16]  C. L. Bird,et al.  Red cell and plasma folate, folate consumption, and the risk of colorectal adenomatous polyps. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  E. Giovannucci Epidemiologic studies of folate and colorectal neoplasia: a review. , 2002, The Journal of nutrition.

[18]  A. Neugut,et al.  Epidemiology of colorectal adenomatous polyps. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  E. Riboli,et al.  Serum folate, homocysteine and colorectal cancer risk in women: a nested case–control study , 1999, British Journal of Cancer.

[20]  L. Kupper,et al.  Micronutrients and the risk of colorectal adenomas. , 1996, American journal of epidemiology.

[21]  M. C. Archer,et al.  Effects of dietary folate on the development and progression of mammary tumors in rats. , 2005, Carcinogenesis.

[22]  A. Folsom,et al.  Relationship of Folate, Vitamin B-6, Vitamin B-12, and Methionine Intake to Incidence of Colorectal Cancers , 2002, Nutrition and cancer.

[23]  D. Alberts,et al.  Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence , 2006, International journal of cancer.

[24]  B. Kelleher,et al.  Microbiological assay for vitamin B12 performed in 96-well microtitre plates. , 1991, Journal of clinical pathology.

[25]  V. Steele,et al.  Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[26]  N. Matsubara,et al.  BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum , 2004, Gut.

[27]  I. Eto,et al.  Effects of folate deficiency and supplementation on methylnitrosourea-induced rat mammary tumors. , 1992, Journal of the National Cancer Institute.

[28]  P. JaraVega Nutrition in health and disease , 2001 .

[29]  A. A. Liakishev [Homocysteine lowering with folic acid and B vitamins in vascular disease]. , 2006, Kardiologiia.

[30]  M. Ehrlich,et al.  The 5-methylcytosine content of DNA from human tumors. , 1983, Nucleic acids research.

[31]  J. Mason,et al.  Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. , 2000, Cancer research.

[32]  C. la Vecchia,et al.  Dietary Folate and Risk of Prostate Cancer in Italy , 2005, Cancer Epidemiology Biomarkers & Prevention.

[33]  B. Ames,et al.  2 DNA damage in folate deficiency , 1995 .

[34]  L. Poirier,et al.  Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. , 1995, Cancer research.

[35]  E. Montgomery,et al.  Serrated Polyps of the Large Intestine: A Practical Approach , 2007 .

[36]  G. Beck,et al.  A Randomized Trial of Aspirin to Prevent Colorectal Adenomas , 2003 .

[37]  S. Hinrichs,et al.  Delayed tumor onset in transgenic mice fed a low-folate diet. , 1992, Journal of the National Cancer Institute.

[38]  D. Alberts,et al.  Folate and colorectal neoplasia: relation between plasma and dietary markers of folate and adenoma recurrence. , 2004, The American journal of clinical nutrition.

[39]  R. Sandler,et al.  Epidemiology of colorectal adenomas. , 1994, Epidemiologic reviews.

[40]  G. Paspatis,et al.  Folate status and adenomatous colonic polyps , 1995, Diseases of the colon and rectum.

[41]  K. Rasmussen Solid-phase sample extraction for rapid determination of methylmalonic acid in serum and urine by a stable-isotope-dilution method. , 1989, Clinical chemistry.

[42]  Young-In Kim Folate, colorectal carcinogenesis, and DNA methylation: Lessons from animal studies , 2004, Environmental and molecular mutagenesis.

[43]  A. Feinberg,et al.  Hypomethylation of DNA from benign and malignant human colon neoplasms. , 1985, Science.

[44]  E. Rimm,et al.  Folate, methionine, and alcohol intake and risk of colorectal adenoma. , 1993, Journal of the National Cancer Institute.

[45]  G. Shaw,et al.  PERICONCEPTIONAL VITAMIN USE, DIETARY FOLATE, AND THE OCCURRENCE OF NEURAL TUBE DEFECTS , 1995, Epidemiology.

[46]  B. Rump,et al.  Colorectal adenomas and diet: a case-control study. Colorectal Adenoma Study Group. , 2001, Digestive diseases and sciences.

[47]  V. Moreno,et al.  Diet and colorectal adenomas: A case‐control study in majorca , 1993, International journal of cancer.

[48]  D. Rubin,et al.  Statistical Analysis with Missing Data. , 1989 .

[49]  J. Baron,et al.  Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas. , 1998, Journal of the National Cancer Institute.

[50]  I. Rosenberg,et al.  Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. , 1992, Cancer research.

[51]  B. Rump,et al.  Colorectal Adenomas and Diet , 2004, Digestive Diseases and Sciences.

[52]  A. Neugut,et al.  Vitamin and calcium supplement use is associated with decreased adenoma recurrence in patients with a previous history of neoplasia , 1999, Diseases of the colon and rectum.

[53]  E. Rimm,et al.  Alcohol, low-methionine--low-folate diets, and risk of colon cancer in men. , 1995, Journal of the National Cancer Institute.

[54]  Rachael Stolzenberg-Solomon,et al.  Null association between prostate cancer and serum folate, vitamin B(6), vitamin B(12), and homocysteine. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[55]  J. Mason,et al.  Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. , 1996, Gut.

[56]  Nicole A. Lazar,et al.  Statistical Analysis With Missing Data , 2003, Technometrics.

[57]  G. Smith,et al.  Taking folate in pregnancy and risk of maternal breast cancer , 2004, BMJ : British Medical Journal.